Ann Hynes

Mizuho | Healthcare

Ann Hynes is an analyst from Mizuho specializing in the Healthcare sector. Ranked #1800 out of 4655 analysts, they have issued 47 stock ratings with a success rate of 85.38% and an average return of 14.29%.

Ann Hynes has a well-established track record, with 47 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 85.38% and an average return of 14.29%, underscoring their expertise and ability to identify winning opportunities for investors.

#1800

Out of 4655

47

Total Ratings

+85.38%

Success Rate

+14.29%

Average Return

Recent Ratings Analysis

SEM

May 13, 2026

Target

$16.50

Current

$16.45

Performance

—

Ann Hynes rated SEM as Neutral on May 13, 2026, setting a price target of 16.5. The Hold stance appears justified, as shares hovered around 16.45 with a % move.

FTRE

May 12, 2026

Target

$13.00

Current

$14.61

Performance

0.00%

On May 12, 2026, FTRE was given a Neutral rating by Ann Hynes, with a target price of 13. Market indecision, reflected in sideways trading near 14.61, supported the cautious call.

BTSG

May 05, 2026

Target

$61.00

Current

$55.50

Performance

7.89%

BTSG received a Outperform rating from Ann Hynes on May 05, 2026, aiming for 61. Momentum has favored the Buy call, with shares climbing from 55.5 to 55.5, rewarding those who trusted the recommendation.

MOH

Mar 12, 2026

Target

$220.00

Current

$191.58

Performance

28.41%

On Mar 12, 2026, Ann Hynes published a Outperform outlook on MOH, with a target of 220. Shares gained 28.41%, underscoring the accuracy of the bullish outlook toward 220.

THC

Mar 12, 2026

Target

$265.00

Current

$195.88

Performance

-12.84%

Ann Hynes on Mar 12, 2026 assigned THC a Outperform rating, with a price target of 265. The call has struggled to gain traction, with shares losing 12.84%.

CNC

Mar 11, 2026

Target

$47.00

Current

$59.31

Performance

65.39%

On Mar 11, 2026, Ann Hynes reaffirmed CNC with a Neutral rating, targeting 47. Market strength beyond 59.31 went further than the conservative outlook suggested.

ELV

Mar 11, 2026

Target

$413.00

Current

$393.30

Performance

35.72%

ELV was rated Outperform by Ann Hynes on Mar 11, 2026, with a price objective of 413. A bullish response from the market helped close the gap of 19.70 to the target.

SGRY

Mar 05, 2026

Target

$19.00

Current

$13.97

Performance

—

On Mar 05, 2026, Ann Hynes initiated coverage on SGRY with a Outperform rating and target of 19. Neutral price movement of % leaves room for interpretation.

HCA

Feb 25, 2026

Target

$585.00

Current

$429.69

Performance

-20.51%

Ann Hynes issued a Outperform recommendation for HCA on Feb 25, 2026, price target set at 585. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

CRL

Feb 20, 2026

Target

$215.00

Current

$168.69

Performance

-0.14%

On Feb 20, 2026, CRL was evaluated by Ann Hynes, who gave a Neutral rating and target of 215. Hold sentiment was validated by subdued trading with no breakout beyond 168.69.

DGX

Feb 12, 2026

Target

$235.00

Current

$190.18

Performance

-8.06%

Ann Hynes rated DGX as Outperform on Feb 12, 2026, setting a price target of 235. The stock has underperformed, dropping 8.06% despite the bullish target of 235.

UNH

Feb 05, 2026

Target

$350.00

Current

$396.39

Performance

47.60%

On Feb 05, 2026, UNH was given a Outperform rating by Ann Hynes, with a target price of 350. The stock rallied 47.60% after the rating, narrowing the gap to the target of 350 and validating the bullish stance.

ARDT

Dec 18, 2025

Target

$20.00

Current

$10.07

Performance

—

ARDT received a Outperform rating from Ann Hynes on Dec 18, 2025, aiming for 20. Price action was muted, as shares hovered around 10.07 despite the bullish outlook.

ACHC

Dec 18, 2025

Target

$22.00

Current

$26.02

Performance

—

On Dec 18, 2025, Ann Hynes published a Neutral outlook on ACHC, with a target of 22. Sideways action left the Hold view intact, with no major move since 26.02.

CVS

Dec 10, 2025

Target

$95.00

Current

$95.15

Performance

20.49%

Ann Hynes on Dec 10, 2025 assigned CVS a Outperform rating, with a price target of 95. The Buy call aligned well with market performance, producing a gain of 20.49%.

MEDP

Oct 24, 2025

Target

$655.00

Current

$419.75

Performance

-30.64%

On Oct 24, 2025, Ann Hynes reaffirmed MEDP with a Outperform rating, targeting 655. Shares slid 30.64% despite the recommendation, highlighting downside risks.

LH

Oct 17, 2025

Target

$320.00

Current

$257.35

Performance

-10.00%

LH was rated Outperform by Ann Hynes on Oct 17, 2025, with a price objective of 320. This case shows how bullish projections can fail, with the stock now below 257.35.

HUM

Oct 09, 2025

Target

$345.00

Current

$295.35

Performance

1.63%

On Oct 09, 2025, Ann Hynes initiated coverage on HUM with a Outperform rating and target of 345. Neutral price movement of 1.63% leaves room for interpretation.

IQV

Jul 25, 2025

Target

$225.00

Current

$175.06

Performance

-12.11%

Ann Hynes issued a Outperform recommendation for IQV on Jul 25, 2025, price target set at 225. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

ICLR

Jul 25, 2025

Target

$225.00

Current

$121.94

Performance

-34.79%

On Jul 25, 2025, ICLR was evaluated by Ann Hynes, who gave a Outperform rating and target of 225. Investors saw limited payoff as shares fell short of the 225 target.

MD

Nov 19, 2024

Target

$15.00

Current

$23.68

Performance

62.08%

Ann Hynes rated MD as Neutral on Nov 19, 2024, setting a price target of 15. Despite the Hold call, shares climbed 62.08% to 23.68, revealing unexpected momentum.

EHC

Apr 25, 2024

Target

$95.00

Current

$108.08

Performance

30.64%

On Apr 25, 2024, EHC was given a Buy rating by Ann Hynes, with a target price of 95. The stock rallied 30.64% after the rating, narrowing the gap to the target of 95 and validating the bullish stance.

Frequency Asked Questions

Who is Ann Hynes?

Ann Hynes is an analyst from Mizuho specializing in the Healthcare sector.

What is Ann Hynes's success rate?

Ann Hynes currently has a success rate of +85.38%.

How many ratings has Ann Hynes issued?

Ann Hynes has issued 47 stock ratings so far.

What is the average return of Ann Hynes's calls?

Their stock ratings have generated an average return of +14.29%.

What is Ann Hynes's ranking?

Ann Hynes is ranked #1800 out of 4655 analysts.

What types of ratings does Ann Hynes give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Ann Hynes?

You can follow Ann Hynes by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Ann Hynes?

Their latest rating was a Hold on SEM issued on 2026-05-13.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep